Concepedia

Kai Hoehlig

KH

Statistics

Publications

16

Citations

2.4K

H-Index

15

Active since

2007

Affiliations

Noxxon Pharma (Germany)(Current)

University of Edinburgh

German Rheumatism Research Centre

Aptar (Germany)

Universidad de Navarra

Kai Hoehlig is an author at Noxxon Pharma (Germany) specializing in life sciences, immunology, and innate immunity.

ORCID

Publications per year

2007–2025

16

Publications

16

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

Ping Shen, Toralf Roch, Vicky Lampropoulou et al. · Nature · 2014 · 1K citations · Full text

, , +16

TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity

Vicky Lampropoulou, Kai Hoehlig, Toralf Roch et al. · The Journal of Immunology · 2008 · 422 citations

, , +17

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Daniel Ajona, Sergio Ortiz‐Espinosa, Haritz Moreno et al. · Cancer Discovery · 2017 · 255 citations

, , +17

Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade

Dirk Zboralski, Kai Hoehlig, Dirk Eulberg et al. · Cancer Immunology Research · 2017 · 165 citations

, , +17

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Sergio Ortiz‐Espinosa, Xabier Morales, Yaiza Senent et al. · Cancer Letters · 2021 · 121 citations

, , +16

1–5 of 16